Impact of chemotherapy on antioxidant micronutrient levels in patients with mature lymphoid malignancies
DOI:
https://doi.org/10.15584/ejcem.2021.3.1Keywords:
antioxidant micronutrients, chemotherapy, haematologic malignanciesAbstract
Introduction. Cancer treatments are now intense and are associated with nutritional deficiencies. The nutritional status of a patient may influence the tolerability of chemotherapy.
Aim. We investigated the effects of chemotherapy on serum levels of trace elements (copper, iron, manganese, selenium, and zinc) and vitamins (A, C, and E) in patients with mature lymphoid malignancies (MLMs) at diagnosis and after 3 months.
Material and methods. A case-control study of adults diagnosed with and treated for various MLMs. Thirty-nine cases and 39 age and sex-matched controls were recruited into this study. Venous blood samples were collected from the controls, cases at baseline and after 3 months of chemotherapy. Trace elements were determined by AAS while vitamins were determined by HPLC.
Results. The levels of trace elements and antioxidant vitamins A and E were significantly higher (p<0.001) in cases than in controls while vitamin C was lower in cases compared to controls (p=0.005). After 3 months of treatment, 28 patients were available for analysis. There was a significant decline (p<0.001) in all the levels of trace elements and vitamins after chemotherapy.
Conclusion. Chemotherapy is associated with a significant reduction in antioxidants levels in patients with MLMs.
Downloads
References
Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood. 2008;112(12):4384-4399.
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390.
Carina L, Susana V, Elisabete C, Manuel G, Miguel B. Micronutrients intake associated with DNA damage assessed by in a human biomonitoring study. Front Genet. 2015;6:1-8.
Mut-Salud N, Álvarez PJ, Garrido JM, et al. Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results. Oxid Med Cell Longev. 2016;2016:6719534.
Khan A, Tania M, Zhang D, Chen H. Antioxidant Enzymes and Cancer. Chin J Cancer Res. 2010;22(2):87-92.
Shinde A, Ganu J, Naik P. Effect of Free Radicals & Antioxidants on Oxidative Stress : A Review. J Dent Allied Sci. 2012;1(2):63-66.
Malihi Z, Kandiah M, Chan YM, et al. The effect of dietary intake changes on nutritional status in acute leukaemia patients after first induction chemotherapy. Eur J Cancer Care (Engl). 2015;24(4):542-552.
Gröber U, Holzhauer P, Kisters K, Holick MF, Adamietz IA. Micronutrients in Oncological Intervention. Nutrients. 2016;8(163):1-30.
Ollberding NJ, Maskarinec G, Conroy SM et al. Prediagnostic circulating carotenoid levels and the risk of non-Hodgkin lymphoma: the Multiethnic Cohort. Blood. 2012;119(24):5817-5823.
Ajila CM, Brar SK. Role of Dietary Antioxidants in Cancer. In: Shankar S, Srivastava R. (eds) Nutrition, Diet and Cancer. Springer, Dordrecht, 2012: 377-412.
Pal D, Banerjee S. Dietary-induced cancer prevention : An expanding research arena of emerging diet related to healthcare system. J Adv Pharm Tech Res. 2012;3(1):16-25.
Turati F, Rossi M, Pelucchi C, Levi F, La Vecchia C. Fruit and vegetables and cancer risk : a review of southern European studies. Br J Nutr. 2016;113(52):102-110.
Chiu BC, Kwon S, Evens AM, Weisenburger DD. Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2011;22:1183-1195.
Di Pierro F. Antioxidants and cancer : a debate on prevention, progression, hormesis, and cruciferous vegetables. Nutrafoods. 2015;14:175-179.
Wang L, Sesso HD, Glynn RJ, et al. Vitamin E and C supplementation and risk of cancer in men : posttrial follow-up in the Physicians ’ Health Study II randomized trial 1 – 4. Am J Clin Nutr 2014;100(3):915-923.
Vinceti M, Dennert G, Crespi CM, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2015;3:1-147.
Poljsak B, Milisav I. The Neglected Significance of “ Antioxidative Stress .” Oxid Med Cell Longev. 2012;2012:1-12.
Ames BN. Prevention of mutation, cancer, and other age-associated diseases by optimizing micronutrient intake. J Nucleic Acids. 2010;2010:473-479.
Kaneko J. Clinical Biochemistry of Animals. 4th ed. JJ K, editor. New York: Academic Press Inc; 1999:932.
Edem VF, Ige O, Arinola OG. Plasma vitamins and essential trace elements in newly diagnosed pulmonary tuberculosis patients and at different durations of anti-tuberculosis chemotherapy. Egypt J Chest Dis Tuberc. 2015;64(3):675-679.
Asfour IA, Hegab HM, Mohammed RM, et al. Assessment of copper, zinc and nitric oxide status in patients with chronic lymphocytic leukemia. Can Res Metastasis. 2017;1(2):3-8.
Abdelgawad MI, Mohammed HSE. Overview of Angiogenesis in Upper Egypt Open Hodgkin’s Lymphoma Patients. Qual Prim Care. 2016;24(3):125-132.
Mohammad-Hassan KA, Asoudeh M, Hosein Fallahi Kord G, et al. Copper and zinc in stage I multiple myeloma : relation with ceruloplasmin, lipid peroxidation, and superoxide dismutase activity. Horm Mol Biol Clin Investig. 2018;37(3):1-6.
Akanni EO, Onuegbu AJ, Adebayo TO, Eegunranti BA, Oduola T. Assessment of Some Selected Trace Metals in Chronic Myeloid Leukemia Patients in a Tertiary Health Facility in South West Nigeria. Asian J Med Sci. 2013;5(4):71-75.
Kaiafa GD, Saouli Z, Diamantidis MD, et al. Copper levels in patients with hematological malignancies. Eur J Intern Med. 2012;23:738-741.
Galloway P, Mcmillan DC, Sattar N. Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem. 2000;37:289-297.
Ströhle A, Zänker K, Hahn A. Nutrition in oncology : The case of micronutrients. Oncol Rep. 2010;24:815-828.
Zhang C, Zhang F. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell. 2015;6(2):88-100.
Bystrom LM, Guzman ML, Rivella S. Iron, and ROS : Friends or Foes of Cancer Cells? Antioxid Redox Signal. 2014;20(12):1917-1924.
Stevens J, Waters R, Kassam S, et al. Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies. Br J Haematol. 2011;154:448-456.
Edem VF, Ige O, Arinola OG. Plasma vitamins and essential trace elements in multi-drug resistant tuberculosis patients before and during chemotherapy. Egypt J Chest Dis Tuberc. 2016;65(2):441-445.
Sharma A, Tripathi M, Satyam A, Kumar L. Study of antioxidant levels in patients with multiple myeloma. Leuk Lymphoma. 2009;50(5):809-815.
Mehdi WA, Zainulabdeen JA, Mehde AA. Investigation of the Antioxidant Status in Multiple Myeloma Patients : Effects of Therapy. Asian Pacific J Cancer Prev. 2013;14(6):3663-3667.
Shenkin A, Roberts NB. Vitamins and Trace Elements. In: Carl A. Burtis ERA, Bruns DE, editors. Tietz Textbook of Clinical Chemistry And Molecular Diagnostics. 5th ed. 3251 Riverport Lane St. Louis, Missouri 63043: Elsevier; 2012:895-983.
Conklin KA, Nicolson GL. Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy. Curr Cancer Ther Rev. 2008;4(1):66-76.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
